{
  "timestamp": "2025-07-28T21:33:15.627Z",
  "totalAssets": 2,
  "successfulRuns": 0,
  "failedRuns": 2,
  "averageScore": null,
  "totalCriticalIssues": 0,
  "recommendations": [],
  "assetDetails": [
    {
      "asset": {
        "id": 1,
        "target": "GLP-1 Receptor",
        "indication": "Type 2 Diabetes",
        "therapeuticArea": "Endocrinology",
        "geography": "US",
        "developmentPhase": "Phase 3",
        "description": "High-value diabetes market with established GLP-1 class"
      },
      "score": 0,
      "criticalIssues": [],
      "recommendation": "N/A",
      "responseTime": 0,
      "cost": 0,
      "finalQualityScore": 0
    },
    {
      "asset": {
        "id": 2,
        "target": "TGF-Î²",
        "indication": "Idiopathic Pulmonary Fibrosis",
        "therapeuticArea": "Respiratory",
        "geography": "EU",
        "developmentPhase": "Phase 2",
        "description": "Orphan disease with high unmet need and premium pricing"
      },
      "score": 0,
      "criticalIssues": [],
      "recommendation": "N/A",
      "responseTime": 0,
      "cost": 0,
      "finalQualityScore": 0
    }
  ],
  "systemPerformance": {
    "averageResponseTime": 0,
    "totalCost": 0,
    "averageValidationCycles": 0,
    "averageQualityScore": 0
  }
}